Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy
Ho Cheol Shin, Jongwon Seo, Byung Woog Kang, Joon Ho Moon, Yee Soo Chae, Soo Jung Lee, Yoo Jin Lee, Seoae Han, Sang Kyung Seo, Jong Gwang Kim, Sang Kyun Sohn, Tae-In Park
Korean J Intern Med. 2014;29(6):785-792.   Published online 2014 Oct 31     DOI:
Citations to this article as recorded by Crossref logo
CXCR 4 mutations in lymphoplasmacytic lymphoma lead to altered CXCR 4 expression
Laura S. Hiemcke‐Jiwa, Roos J. Leguit, N. Mehdi Jiwa, Manon M. H. Huibers, Monique C. Minnema
British Journal of Haematology.2019; 185(5): 966.     CrossRef
Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels
Weijie Zhong, Zhigang Zhu, Xin Xu, Hui Zhang, Huabao Xiong, Qingshan Li, Yaming Wei
Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
The significance of chemokines in diffuse large B-cell lymphoma: a systematic review and future insights
Qian Huang, Feifei Liu, Jianzhen Shen
Future Oncology.2019; 15(12): 1385.     CrossRef
The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro
Katrin Pansy, Julia Feichtinger, Barbara Ehall, Barbara Uhl, Miriam Sedej, David Roula, Beata Pursche, Axel Wolf, Manuel Zoidl, Elisabeth Steinbauer, Verena Gruber, Hildegard T Greinix, Katharina T. Prochazka, Gerhard G. Thallinger, Akos Heinemann, Christ
International Journal of Molecular Sciences.2019; 20(19): 4740.     CrossRef
Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma
Zi-Zhen Xu, Jian-Kang Shen, Shu-Qing Zhao, Jun-Min Li
Leukemia & Lymphoma.2018; 59(6): 1451.     CrossRef
The role of G protein-coupled receptors in lymphoid malignancies
Adrienne Nugent, Richard L. Proia
Cellular Signalling.2017; 39: 95.     CrossRef
The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
Linn Reinholdt, Maria Bach Laursen, Alexander Schmitz, Julie Støve Bødker, Lasse Hjort Jakobsen, Martin Bøgsted, Hans Erik Johnsen, Karen Dybkær
Biomarker Research.2016;[Epub]     CrossRef
Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks
Jennifer Enciso, Hector Mayani, Luis Mendoza, Rosana Pelayo
Frontiers in Physiology.2016;[Epub]     CrossRef
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin
Susann Stollberg, Daniel Kämmerer, Elisa Neubauer, Stefan Schulz, Ingrid Simonitsch-Klupp, Barbara Kiesewetter, Markus Raderer, Amelie Lupp
Journal of Cancer Research and Clinical Oncology.2016; 142(11): 2239.     CrossRef
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions
Chi Young Ok, Zijun Y Xu-Monette, Ling Li, Ganiraju C Manyam, Santiago Montes-Moreno, Alexandar Tzankov, Carlo Visco, Karen Dybkær, Mark J Routbort, Li Zhang, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D Hsi, William W L C
Modern Pathology.2015; 28(9): 1202.     CrossRef